China's 2026-30 TCM Five-Year Plan: What 1.82B Annual Visits Mean for International Patients

China's State Council Just Set TCM Targets for the Next Five Years

On 23 July 2026, China's State Council approved a new five-year plan for traditional Chinese medicine that runs through 2030. The plan was jointly released by the National Administration of Traditional Chinese Medicine and the National Development and Reform Commission, and it does something unusual for a TCM policy document — it commits to specific disease-level clinical breakthroughs on the same timeline as pharmaceutical research targets.

The headline goal: by 2030, China aims to establish a TCM service system that covers the entire population across the full life cycle, with breakthroughs in cardiovascular and cerebrovascular disease, cancer, kidney disorders, and infectious diseases — the same four disease categories that dominate the country's Western-medicine research agenda.

This matters for international patients because the plan is not abstract. It builds on what is already in place at every Chinese tertiary hospital today.

Source: China Daily / Xinhua, "China to boost traditional Chinese medicine inheritance, innovation, capacity," published 23 July 2026 (chinadaily.com.cn)

What the 2025 Baseline Looks Like in Numbers

Before the 2030 targets, the plan benchmarks against the 14th Five-Year Plan period (2021-2025). The data is concrete:

The 96.26% figure is the most important one for medical tourists. It means when a foreign patient is referred to a Western tertiary hospital in Beijing, Shanghai, Guangzhou, Chengdu, or Hangzhou, the TCM department is already there as an institutional peer — not an alternative-medicine clinic tucked into a corner.

For comparison: in most US hospitals, an "integrative medicine" or "acupuncture" service, if it exists, is a separate clinic with separate billing and no formal connection to the oncology or cardiology department. In China, the TCM physician often sits in the same multidisciplinary team meeting.

What the Plan Targets for 2030 — Disease by Disease

The plan is explicit about which conditions TCM should be making measurable progress on by 2030. The four named priorities match the disease burden of an aging Chinese population — and the disease burden of the foreign patients who most often travel to China for treatment.

The plan also names two clinical capacity gaps that international patients frequently hit: geriatric care and pediatric care. TCM hospitals are directed to set up mental health and sleep clinics, and to strengthen their capacity for elderly and pediatric patients. This is a direct response to China's aging population and low birth rate — but it also creates a clear access pathway for foreign families looking for non-pharmaceutical sleep and behavioral-health support.

The "High-Quality Integration" Clause — and Why It Matters for Foreign Cancer Patients

The most concrete clinical commitment in the 2026-30 plan is the "high-quality integration of TCM and Western medicine" language. This is not new rhetoric — China has had integrated medicine for decades — but the plan upgrades it from a slogan to a research and capacity-building mandate.

For an international cancer patient, this translates to a specific, repeatable experience at any major Chinese cancer center:

None of this is experimental. It is the standard of care inside China's tertiary cancer centers. The 2026-30 plan commits the government to keep funding this infrastructure through 2030, which for foreign patients means it will not quietly disappear when budgets tighten.

For a deeper look at how this works in practice, see our guide to integrated Chinese-Western medicine in China and our TCM traditional Chinese medicine guide.

What the Plan Says About TCM Going Global — and What That Means for Access

The plan's international language is short but specific: China will "further expand opening up in the TCM sector, encourage the industry to play a more active role in global health governance, and deepen international exchanges and mutual learning."

In practice, the 2025-2026 data already shows this happening:

• Germany: Anhui Jiren Pharmaceutical's Shufeng Jiedu granules have been on the shelves of the Bahnhof-Apotheke pharmacy chain for over six years — nearly 200,000 bottles sold at €39.90 each.
• Russia: Tianjin Da Ren Tang's Suxiao Jiuxin Pills have been a registered prescription heart-attack medication since 1997.
• Hainan: The Sanya Hospital of Traditional Chinese Medicine has built dedicated foreign-client pathways, with Russian and Gulf-state patients making up the bulk of inbound TCM-only stays.

For an international patient considering a TCM-only stay in China, the practical question is not whether the government supports TCM — that question has been settled for decades. The question is which hospital can serve a foreign patient in English or Bahasa Indonesia or Vietnamese, with consistent herbal quality, and with a Western-trained physician on call if anything goes wrong.

For most foreign patients, that narrows the list to:

For patients comparing cost across the region, a 10-14 day TCM course in China runs roughly 60-75% less than comparable TCM programs in Singapore, Korea, or the United States — and Singapore has very limited TCM capacity outside of traditional Chinese medicine practitioners without hospital integration. China's lead is not just price. It is the institutional integration of TCM with Western medicine inside the same hospital system, which very few countries outside China, Korea, and parts of Germany can match.

See our guide to why international patients choose China for medical treatment for the broader comparison.

What to Watch Over the Next 12-18 Months

The plan does not name specific delivery dates, but several concrete signals will show whether it is on track:

1. Pediatric and geriatric TCM departments opening at provincial cancer and cardiology centers — these are the most under-built areas today, and foreign families with elderly parents or children with chronic conditions should watch for them.
2. Mental health and sleep clinics inside TCM hospitals — the plan explicitly directs TCM hospitals to build these. For foreign patients who want non-benzodiazepine sleep support or anxiety management, this is the most concrete new capacity.
3. International department capacity at Tier-2 city TCM hospitals — today, most foreign patients cluster at the four or five best-known hospitals. If the plan expands international capacity to provincial capitals, it will materially change what foreign patients can access.
4. The integration of TCM into oncology clinical trial protocols — the plan calls for "clarifying the mechanisms" of TCM in disease prevention and treatment. This means more published RCTs, which in turn will make TCM support easier for foreign oncologists to recommend.

For patients planning a medical trip in 2026 or 2027, none of these are abstract. They will show up as concrete new service lines at the hospitals where they are already being seen.

How China Hospitals Guide Helps

China Hospitals Guide provides independent coordination for international patients seeking treatment at Chinese hospitals — including integrated TCM-Western oncology, post-stroke rehabilitation programs, and chronic-disease TCM programs at Sanya, Dongzhimen, Yueyang, Guang'anmen, and the Guangzhou University of TCM network.

What we do:

• Match you with 2-3 hospitals for your specific condition
• Pre-arrange English (or Bahasa Indonesia, Vietnamese, Russian, Arabic) translation
• Coordinate TCM-Western integrated treatment plans for cancer, stroke recovery, and chronic disease
• Provide visa invitation letters and arrival logistics
• Coordinate herbal prescriptions for export where regulations allow

Start a free case review — no commitment, no fee.

Related Reading

• Integrated Chinese-Western Medicine in China: How It Works in Practice
• TCM Traditional Chinese Medicine Guide for International Patients
• Why International Patients Choose China for Medical Treatment in 2026
• TCM Going Global: How Shufeng Jiedu, Suxiao Jiuxin Pills and AI Workflows Reached 196 Countries
• Hong Kong Chinese Medicine Hospital: Stroke and Back Pain Programmes Launch

Sources:

• China Daily / Xinhua, "China to boost traditional Chinese medicine inheritance, innovation, capacity" (23 July 2026) — chinadaily.com.cn
• China Daily / Xinhua, "China unveils 2026-30 plan to strengthen TCM services" (23 July 2026) — chinadaily.com.cn